The use of paclitaxel and cisplatin in a patient with epithelial ovarian cancer and human immunodeficiency virus

Gynecologic Oncology

Volumn 76, Issue 1, 2000, Pages 118-122

  Knox, Stacey N ^a   Robinson, Jubilee B ^b   Im, Dwight D ^b   Logan, Lisa ^b   Rosenshein, Neil B ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MERCY MEDICAL CENTER   (United States)

Author keywords

Cisplatin; HIV; Ovarian cancer; Paclitaxel

Indexed keywords

ANTIGEN P24; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CISPLATIN; NEOPTERIN; PACLITAXEL;

ADULT; ARTICLE; CASE REPORT; CHEMOTHERAPY; DISEASE COURSE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOTOXICITY; MORBIDITY; OVARY CANCER; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0033984006     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5590     Document Type: Article

References (8)

1. MMWR. 45:1995;81-84.
2. MMWR. 46:1997;861-867.
3. Preston-Martin S, Levine A, Masri-Lavine L, Hessol N, Lyter D, Silver S, Melnick S. Cancer occurrence in the Women's Interagency HIV Study (WIHS). Int Conf AIDS. 12:1998;128.
4. Sonnerborg A B, von Stedingk L V, Hansson L O, Strannegard O O. Elevated neopterin and beta-2 microglobulin levels in blood and CSF occur early in HIV-1 infection. AIDS. 3:1989;227-283.
5. Rose P G, Cheeseman S H. Advanced ovarian carcinoma managed in an HIV-1 positive patient. Gynecol Oncol. 48:1992;132-134.
6. McGuire W P, Hoskins W, Brady M F. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. N Engl J Med. 334:1996;1.
7. Buckley S L, Molpus K, Carr M, Jones H. Advanced ovarian carcinoma diagnosed during pregnancy in a patient with human immunodeficiency virus infection. Gynecol Oncol. 50:1993;352-356.
8. Fishman D A, Viscarello R, Cass I, Schwartz P E. Effect of combination chemotherapy with cisplatin and cyclophosphamide on human immunodeficiency virus type-1 surrogate markers in a patient with advanced epithelial ovarian cancer. Gynecol Oncol. 57:1995;105-108.